Diabetes and obesityDrug intelligence

Mounjaro

Tirzepatide

Dual GIP and GLP-1 receptor agonist. Developed by Eli Lilly. Clinical, regulatory, and source evidence are connected below.

Company: Eli Lilly
Target / MOA: GIPR · GLP-1R
Aliases: Mounjaro · Zepbound · LY3298176

Signals: 24
Clinical trials: 20
Approvals: 1
Evidence sources: 23

Latest signals

What changed

The three most recent source-backed changes linked to this drug.

clinical trialApr 2, 2026ClinicalTrials.gov

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

Phase 4 · RECRUITING · Ali Aminian

clinical trialMar 31, 2026ClinicalTrials.gov

Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity

N/A · NOT_YET_RECRUITING · Radboud University Medical Center

clinical trialMar 27, 2026ClinicalTrials.gov

Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment

NA · RECRUITING · University of Exeter

Clinical trials

Key active studies

A focused view of recently updated studies · 20 linked records.

Phase 4RECRUITINGNCT06803888

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

Ali Aminian · Updated Apr 2, 2026

N/ANOT YET RECRUITINGNCT07504172

Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity

Radboud University Medical Center · Updated Mar 31, 2026

NARECRUITINGNCT07457437

Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment

University of Exeter · Updated Mar 27, 2026

Phase 2NOT YET RECRUITINGNCT06732245

Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese

Biomed Industries, Inc. · Updated Mar 27, 2026

Phase 2RECRUITINGNCT06651177

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

T. John Winhusen, PhD · Updated Mar 24, 2026

Phase 3RECRUITINGNCT06246799

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

The University of Texas Health Science Center at San Antonio · Updated Mar 10, 2026

Regulatory timeline

Approvals and agency activity

Verified regulatory records in reverse chronological order.

Feb 24, 2026 · MHRA UK

Fake Mounjaro (tirzepatide) KwikPen 15mg pre-filled pens

Feb 24, 2026 · MHRA UK

Falsified Mounjaro KwikPen 15mg pre-filled pens

Feb 24, 2026 · Pharmac New Zealand

Wegovy and Mounjaro for weight loss not funded

Nov 1, 2024 · FDA

MOUNJARO

Related intelligence

Connected drugs

Records connected through the current intelligence graph.

Source evidence

Where this profile comes from

Facts link back to original registries, regulators, labels, and publishers. Counts change as source records update.

ClinicalTrials.govofficial · Latest Apr 2, 202620 MHRA UKgeneral media · Latest Feb 24, 20262 Pharmac New Zealandofficial · Latest Feb 24, 20261 FDAofficial · Latest Nov 1, 20241

Professional referenceThis profile summarizes linked public evidence. It is not medical, legal, regulatory, or investment advice. Verify decisions against original sources.